Test environment running 7.6.6

Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Delayed circulatory failure due to the induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in anaesthetized rats

Abstract

1 This study investigates the effect of lipoteichoic acid (LTA) from the cell wall of Staphylococcus aureus, a micro‐organism without endotoxin, on haemodynamics and induction of nitric oxide synthase (iNOS) in the anaesthetized rat. 2 Intravenous injection of LTA (10 mg kg−1) resulted in a decrease in blood pressure from 123 ± 1 mmHg to 83 ± 7 mmHg after 270 min (P< 0.001) and a reduction of the pressor response to noradrenaline (1 μg kg−1) from 33 ± 1 mmHg.min to 23 ± 3 mmHg.mm after 270 min (P>0.05). 3 The delayed circulatory failure (hypotension and vascular hyporeactivity) caused by LTA was prevented by pretreatment of rats with dexamethasone (10 mg kg−1, 60 min prior to LTA) or the nitric oxide synthase inhibitor NG‐monomethyl‐l‐arginine (l‐NMMA, 10 mg kg−1h−1, i.v. infusion starting 30 min prior to LTA). 4 In contrast, treatment of rats with polymyxin B (0.05 mg kg−1), an agent which binds endotoxin (lipopolysaccharides, LPS), did not affect the delayed circulatory failure caused by LTA. Polymyxin B, however, attenuated the hypotension and vascular hyporeactivity to noradrenaline afforded by endotoxaemia (2 mg kg−1 LPS, i.v.) for 270 min. 5 The delayed circulatory failure caused by LTA was associated with a time‐dependent increase in (i) the expression of iNOS protein in the lung (Western blot analysis), and (ii) iNOS activity. This increase in iNOS protein and activity was prevented by pretreatment of LTA‐rats with dexamethasone (10 mg kg−1). 6 Intravenous injection of LTA resulted in an increase in serum tumour necrosis factor (TNF)‐α (maximum at 90 min after LTA), which was attenuated by pretreatment of rats with dexamethasone (10 mg kg−1, 60 min prior to LTA). The magnitude of the rise in TNF‐α caused by LTA was similar to the one elicited by LPS (10 mg kg−1, i.v.). 7 Thus, an enhanced formation of nitric oxide following the induction of iNOS contributes importantly to the delayed vascular failure (hypotension and vascular hyporeactivity) caused by LTA in the anaesthetized rat. We suggest that the endogenous release of TNF‐α contributes to the induction of iNOS caused by LTA in vivo. 1995 British Pharmacological Society

Description

Citation

Source

British Journal of Pharmacology

Book Title

Entity type

Access Statement

License Rights

Restricted until